SCHEMBL16623502

SCHEMBL16623502

N#Cc1cccc(F)c1Nc1cc[nH]c(=O)c1C(=N)/C(C=N)=C/N

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
LRRK2 Q5S007 1/20 0.32
MCL1 Q07820 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16623490 0.90
SCHEMBL16623597 0.81 CHUK (0.31)
SCHEMBL17849246 0.74 PARP1 (0.34) LRRK2MCL1
SCHEMBL16726675 0.72
SCHEMBL17849244 0.71 TYK2 (0.40) LRRK2
SCHEMBL16623550 0.68 JAK1 (0.36)
SCHEMBL17849245 0.68 NPC1 (0.41) LRRK2
SCHEMBL16726648 0.66 KDR (0.33)
SCHEMBL16623511 0.66 TYK2 (0.38)
SCHEMBL16623558 0.64 PARP1 (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9371320-B2 Heterocyclic compound TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2016-06-21 US disclosed
US-9371320-B2 Heterocyclic compound TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2016-06-21 US disclosed
EP-2857400-A1 HETEROCYCLIC COMPOUND Takeda Pharmaceutical Company Limited (JP) 2015-04-08 EP disclosed